MediPharm Labs Australia Signs First International White-Label Supply Deal with New Zealand based Helius Therapeutics

MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) a global leader in specialized, research-driven pharmaceutical-quality cannabis extraction, distillation and derivative products, is pleased to announce that…

MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) a global leader in specialized, research-driven pharmaceutical-quality cannabis extraction, distillation and derivative products, is pleased to announce that its subsidiary, MediPharm Labs Australia Pty Ltd (“MediPharm Labs Australia”), has entered into an agreement to supply pharmaceutical-quality (GMP certified), white-label, cannabis oil products to Helius Therapeutics Limited (“Helius Therapeutics”), […]

The post MediPharm Labs Australia Signs First International White-Label Supply Deal with New Zealand based Helius Therapeutics appeared first on Technical420.

Leave a Reply

Your email address will not be published. Required fields are marked *